Study Evaluating Safety of Ragweed Mix Given by Intralymphatic Node Injections

Summary

A safety study conducted on subjects ≥16 years old evaluating the safety of 4 intralymphatic injections of 2 different dose levels of the investigational short and tall ragweed product. Biomarkers will be assessed at baseline and at multiple time points post-treatment.

Timeline

Start

2017-03-30

Primary completion

2017-04-29

Completion

2017-04-29

Drugs

Indications